As of Apr 20
| +0.12 / +0.30%|
The 26 analysts offering 12-month price forecasts for GlaxoSmithKline PLC have a median target of 42.50, with a high estimate of 57.41 and a low estimate of 31.41. The median estimate represents a +6.24% increase from the last price of 40.00.
The current consensus among 27 polled investment analysts is to Hold stock in GlaxoSmithKline PLC. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.